微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Mannheimia haemolytica (Newsom and Cross) Angen et al. |
|---|---|
| 商品货号： | TS202016 |
| Deposited As： | Pasteurella haemolytica Newsom and Cross |
| Strain Designations： | 76-72H (Vaccine) |
| Application： | Used to produce vaccine against Pasteurella haemolytica |
| Isolation： | Derived from existing strain |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 1206: Tryptose broth with thiamine |
| Growth Conditions： | Temperature: 37.0°C |
| Name of Depositor： | Norden Labs. |
| U.S. Patent Number： | |
| References： | Kucera CJ. Modified Pasteurella bacteria and vaccines prepared therefrom. US Patent 4,388,299 dated Jun 14 1983 Kucera CJ. Modified Pasteurella haemolytica bacteria. US Patent 4,506,017 dated Mar 19 1985 Kucera CJ. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom. US Patent 4,626,430 dated Dec 2 1986 derived from ATCC 31611 |